{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:47:18Z","timestamp":1788544038499,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.tox.2023.153469","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T20:53:05Z","timestamp":1677876785000},"page":"153469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Establishment of a point of departure for CBD hepatotoxicity employing human HepaRG spheroids"],"prefix":"10.1016","volume":"488","author":[{"given":"Jinpeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Zagorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert E.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tox.2023.153469_bib1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02085029","article-title":"Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography","volume":"37","author":"Agurell","year":"1981","journal-title":"Experientia"},{"issue":"8","key":"10.1016\/j.tox.2023.153469_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00109-011-0856-x","article-title":"Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer","volume":"90","author":"Aviello","year":"2012","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.tox.2023.153469_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington's disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharm. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.tox.2023.153469_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMc1708349","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"377","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.tox.2023.153469_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"issue":"20","key":"10.1016\/j.tox.2023.153469_bib6","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.tox.2023.153469_bib7","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1212\/WNL.0000000000005254","article-title":"Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome","volume":"90","author":"Devinsky","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tox.2023.153469_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharm."},{"issue":"6","key":"10.1016\/j.tox.2023.153469_bib9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis","volume":"20","author":"Hammell","year":"2016","journal-title":"Eur. J. Pain."},{"issue":"8","key":"10.1016\/j.tox.2023.153469_bib10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.tox.2023.153469_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.tox.2023.153469_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/aivt.2019.0008","article-title":"Functional comparison of HepaRG cells and primary human hepatocytes in sandwich and spheroid culture as repeated-exposure models for hepatotoxicity","volume":"5","author":"Li","year":"2019","journal-title":"Appl. Vitr. Toxicol."},{"issue":"17","key":"10.1016\/j.tox.2023.153469_bib13","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6284","key":"10.1016\/j.tox.2023.153469_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"issue":"6441","key":"10.1016\/j.tox.2023.153469_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tox.2023.153469_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/can.2018.0073","article-title":"Immune Responses Regulated by Cannabidiol","volume":"5","author":"Nichols","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"10.1016\/j.tox.2023.153469_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/bms.1200130206","article-title":"Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration","volume":"13","author":"Ohlsson","year":"1986","journal-title":"Biomed. Environ. Mass Spectrom."},{"issue":"12","key":"10.1016\/j.tox.2023.153469_bib18","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/j.pain.0000000000001052","article-title":"Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis","volume":"158","author":"Philpott","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.tox.2023.153469_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharm. Ther."},{"issue":"1","key":"10.1016\/j.tox.2023.153469_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfx122","article-title":"From the cover: three-dimensional (3D) HepaRG spheroid model with physiologically relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening","volume":"159","author":"Ramaiahgari","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.tox.2023.153469_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/toxsci\/kfz065","article-title":"The power of resolution: contextualized understanding of biological responses to liver injury chemicals using high-throughput transcriptomics and benchmark concentration modeling","volume":"169","author":"Ramaiahgari","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.tox.2023.153469_bib22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s11481-020-09918-7","article-title":"Targeting cannabinoid receptor 2 on peripheral leukocytes to attenuate inflammatory mechanisms implicated in HIV-Associated neurocognitive disorder","volume":"15","author":"Rizzo","year":"2020","journal-title":"J. Neuroimmune Pharm."},{"issue":"8","key":"10.1016\/j.tox.2023.153469_bib23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/epi.14477","article-title":"Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results","volume":"59","author":"Szaflarski","year":"2018","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.tox.2023.153469_bib24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A Phase I, Randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"issue":"10125","key":"10.1016\/j.tox.2023.153469_bib25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tox.2023.153469_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/toxsci\/kfm092","article-title":"A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure","volume":"98","author":"Thomas","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.tox.2023.153469_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/toxsci\/kfp233","article-title":"Use of short-term transcriptional profiles to assess the long-term cancer-related safety of environmental and industrial chemicals","volume":"112","author":"Thomas","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2023.153469_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/toxsci\/kfq355","article-title":"Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment","volume":"120","author":"Thomas","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2023.153469_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/toxsci\/kft094","article-title":"Temporal concordance between apical and transcriptional points of departure for chemical risk assessment","volume":"134","author":"Thomas","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2023.153469_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1744-8069-6-16","article-title":"Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain","volume":"6","author":"Toth","year":"2010","journal-title":"Mol. Pain."},{"issue":"3","key":"10.1016\/j.tox.2023.153469_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","article-title":"Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women","volume":"34","author":"Wall","year":"1983","journal-title":"Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.tox.2023.153469_bib32","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cpt.2071","article-title":"Cannabidiol and abnormal liver chemistries in healthy adults: results of a phase I clinical trial","volume":"109","author":"Watkins","year":"2021","journal-title":"Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.tox.2023.153469_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178302","article-title":"A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling","volume":"12","author":"Yeakley","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tox.2023.153469_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and cytochrome P450 interactions","volume":"17","author":"Zendulka","year":"2016","journal-title":"Curr. Drug Metab."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X23000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X23000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:54:27Z","timestamp":1759535667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X23000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":34,"alternative-id":["S0300483X23000550"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2023.153469","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of a point of departure for CBD hepatotoxicity employing human HepaRG spheroids","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2023.153469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153469"}}